Liquid biopsies: tumor diagnosis and treatment monitoring -

作者: Binh Thanh Vu , Dat Tan Le , Phuc Van Pham

DOI: 10.7603/S40730-016-0035-3

关键词:

摘要: Cancer is a disease with high evolutionary, i.e., malignant, characteristics that change under selective pressure from therapy. Characterization based on molecular or primary tumor properties clinicopathological staging does not fully reflect the state of cancer, especially when cancer cells metastasize. This major reason for failure treatment. Currently, there an urgent need new approaches allow more effective, but less invasive, monitoring status, thereby improving efficacy treatments. With recent technological advances, “liquid biopsies,” isolation intact analysis components are secreted cells, such as nucleic acids exosomes, could be implemented easily. approach would facilitate real-time and accurate measurement critical biomarkers. In this review, we summarize progress in identification circulating using high-resolution discuss acid- exosome-based approaches. The information obtained through liquid biopsies used to gain better understanding cell invasiveness metastatic competence, which then benefit translational applications personalized medicine.

参考文章(73)
Catherine Alix-Panabières, EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients. Recent results in cancer research. ,vol. 195, pp. 69- 76 ,(2012) , 10.1007/978-3-642-28160-0_6
Isabelle Gingras, Roberto Salgado, Michail Ignatiadis, Liquid biopsy: Will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies? Current Opinion in Oncology. ,vol. 27, pp. 560- 567 ,(2015) , 10.1097/CCO.0000000000000223
K. C. Allen Chan, Emily C. W. Hung, John K. S. Woo, Paul K. S. Chan, Sing-Fai Leung, Franco P. T. Lai, Anita S. M. Cheng, Sze Wan Yeung, Yin Wah Chan, Teresa K. C. Tsui, Jeffrey S. S. Kwok, Ann D. King, Anthony T. C. Chan, Andrew C. van Hasselt, Y. M. Dennis Lo, Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program. Cancer. ,vol. 119, pp. 1838- 1844 ,(2013) , 10.1002/CNCR.28001
MICHAEL S. KOPRESKI, FLOYD A. BENKO, CHRISTOPHER D. GOCKE, Circulating RNA as a tumor marker: Detection of 5T4 mRNA in breast and lung cancer patient serum Annals of the New York Academy of Sciences. ,vol. 945, pp. 172- 178 ,(2006) , 10.1111/J.1749-6632.2001.TB03882.X
Paola Gazzaniga, Cristina Raimondi, Chiara Nicolazzo, Raffaella Carletti, Cira di Gioia, Angela Gradilone, Enrico Cortesi, The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells Expert Review of Molecular Diagnostics. ,vol. 15, pp. 925- 932 ,(2015) , 10.1586/14737159.2015.1045491
Ismail Labgaa, Augusto Villanueva, Liquid biopsy in liver cancer. Discovery Medicine. ,vol. 19, pp. 263- 273 ,(2015)
Altay Aliyev, Manjula Gupta, Christian Nasr, Betul Hatipoglu, Mira Milas, Allan Siperstein, Eren Berber, CIRCULATING THYROID-STIMULATING HORMONE RECEPTOR MESSENGER RNA AS A MARKER OF TUMOR AGGRESSIVENESS IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA Endocrine Practice. ,vol. 21, pp. 777- 781 ,(2015) , 10.4158/EP14425.OR
S A Leon, B Shapiro, M J Yaros, D M Sklaroff, Free DNA in the Serum of Cancer Patients and the Effect of Therapy Cancer Research. ,vol. 37, pp. 646- 650 ,(1977)
Zhuo Zhang, Nithya Ramnath, Sunitha Nagrath, Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions. Frontiers in Oncology. ,vol. 5, pp. 209- 209 ,(2015) , 10.3389/FONC.2015.00209
Catherine Alix-Panabières, Klaus Pantel, Real-time liquid biopsy: circulating tumor cells versus circulating tumor DNA. Annals of Translational Medicine. ,vol. 1, pp. 18- 18 ,(2013) , 10.3978/J.ISSN.2305-5839.2013.06.02